Activist BIMIZCI Intensifies Proxy Fight, Citing CEO Fraud, Underperformance, and Entrenched Board
MFIN sits 23% above its 52-week low of $7.85.
Summary
Activist investor BIMIZCI Fund LLC has intensified its proxy contest against Medallion Financial, detailing allegations of CEO fraud, financial underperformance, and poor governance in a direct appeal to shareholders.
Key Events · Corporate Governance and Compliance · MFIN
-
Proxy Contest Escalates
Activist BIMIZCI Fund LLC filed definitive additional materials, including a letter to shareholders, to solicit votes for its three independent director nominees.
-
Allegations of CEO Misconduct
The filing highlights that CEO Andrew Murstein consented to a permanent SEC injunction for securities fraud and paid a $1 million penalty, yet subsequently received a $4.6 million bonus and a promotion.
-
Financial Underperformance Detailed
BIMIZCI points to Medallion's stock trading 50% below its 2013 peak, Q1 2026 profit being the lowest since 3Q20, and an SBA default notice on $73.5 million in subsidiary debentures due to 'unqualified management.'
-
Governance Entrenchment Criticized
The activist group criticizes the board's composition, including multiple family members and long-tenured directors, and actions taken to deter shareholder activism, such as amending the clawback policy and bylaws.
Analysis · MFIN · Finance
This filing from activist investor BIMIZCI Fund LLC escalates its proxy contest, presenting a detailed letter to shareholders. It outlines severe criticisms of Medallion Financial's current leadership, including the CEO's SEC fraud injunction followed by a large bonus, persistent financial underperformance, entrenched governance, and a failure to adapt to industry technology shifts. The filing seeks to replace three current directors with independent nominees, making this a critical battle for the company's future strategic direction and leadership.
At the time of this filing, MFIN was trading at $9.63 on NASDAQ in the Finance sector, with a market capitalization of approximately $229.7M. The 52-week trading range was $7.85 to $11.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.